Association of hsp27 Expression with Nasopharyngeal Carcinoma Cell Proliferation
-
摘要: 目的 探讨hsp27基因对鼻咽癌细胞增殖的影响及其机制。方法利用实时定量PCR检测NP460(正常鼻咽部上皮细胞株）、CNE2(低分化鼻咽癌细胞株）及S18(CNE2的高转移亚克隆）的hsp27转录水平，利用慢病毒转染技术在hsp27转录水平较低的CNE2中过表达hsp27，利用小干扰RNA技术抑制S18细胞内的hsp27，用MTT技术检测过表达或抑制hsp27后细胞增殖速率的变化，同时检测转录因子NF-κB的转录水平的变化，分析hsp27影响鼻咽癌细胞增殖速率的可能机制。结果(1）三种细胞株中的内源性hsp27水平为S18>CNE2>NP460，差异具有统计学意义。(2）在CNE2细胞中过表达hsp27基因后，细胞的增殖速率明显加快，NF-κB转录水平明显上调。(3）抑制S18细胞内的hsp27基因后，细胞的增殖速率明显减缓，NF-κB转录水平明显下调。结论hsp27基因可能通过调节NF-κB信号通路而对鼻咽癌细胞发挥明显的促增殖作用，可设计针对hsp27基因的抗鼻咽癌分子治疗策略。Abstract: Objective To study the role of hsp27 gene in the proliferation of nasopharyngeal carcinoma (NPC)，and further explore the underlying mechanism. Methods The transcription levels of hsp27 in NP460(normal nasopharyngeal epithelial cell lines)，CNE2 (low differentiated NPC cell line) and S18 (highly migratory subclone of CNE2) cell lines were determined by Real Time PCR.Over-expression of hsp27 in CNE2 cells (with low endogenous hsp27 level) was performed by lentivirus infection，and small interference RNA technique was employed to decrease hsp27 in S18 cells (with high endogenous hsp27 level).Then MTT experiment was used to evaluate the proliferation of the hsp27-overexpressed and -inhibited cells.The transcription level of nuclear factor kappa B (NF-κB) was measured as well. Results (1) the endogenous hsp27 level of three cell lines showed significant difference and the order was S18>CNE2>NP460.(2) The proliferation and NF-κB level of CNE2 cells was significantly upregulated with hsp27 over-expression.(3) The growth rate of S18 slowed significantly concurrent with down-regulation of NF-κB after inhibition of hsp27. Conclusion hsp27 plays an important role in the proliferation of NPC cells which may mediates by NF-κB signal pathway.The hsp27 gene would be a potential molecular target for anti-NPC therapy.
-
Key words:
- hsp27 /
- NF-κB /
- nasopharyngeal carcinoma /
- proliferation /
- mechanism
-
-
[1] Tao Q，Chan AT.Nasopharyngeal carcinoma：molecular pathogenesis and therapeutic developments [J].Expert Rev Mol Med，2007，9 (12)：1-24. [2] Ma BB，Hui EP，Chan AT.Systemic approach to improving treatment outcome in nasopharyngeal carcinoma：current and future directions [J].Cancer Sci，2008，99 (7)：1311-1318. [3] Wang RW，Zhou GF，Huang SP，et al.Expression of HSP70/HSP27 protein in residual lesion after NPC radiotherapy [J].Zhong Nan Da Xue Xue Bao(Medical Science)，2009，34 (11)：1091-1095.[王润文，周高峰，黄生鹏，等.鼻咽癌放疗残灶中HSP70/HSP27蛋白的表达[J].中南大学学报(医学版)，2009，34(11)：1091-1095.] [4] Su J，Lu MQ，Xu XH.Progress in the molecule-targeted treatment for nasopharyngeal carcinoma[J].Shandong Yi Yao，2010，50 (16)：104-105.[苏进，鲁明骞，许新华.鼻咽癌分子靶向治疗研究进展[J].山东医药，2010，50 (16)：104-105.] [5] Wu XX，Chen YF.The clinic pathology of the expression of HSP70 and HSP27 in nasopharyngeal carcinoma[J].Zhongguo Yi Shi Za Zhi，2006，8 (10)：1422-1423.[吴显祥，陈云芳.HSP70与HSP27在鼻咽癌中的表达及其临床病理研究[J].中国医师杂志，2006，8 (10)：1422-1423]. [6] Schmittgen TD.Real-time quantitative PCR[J].Methods，2001，25 (4)：383-385. [7] Chen Y，Lin MC，Yao H，et al.Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin [J].Hepatology，2007，46 (1)：200-208. [8] Kim EH，Lee HJ，Lee DH，et al.Inhibition of heat shock protein 27-mediated resistance to DNA damaging agents by a novel PKC delta-V5 heptapeptide [J].Cancer Res，2007，67 (13)：6333-6341. [9] Li GY，Liu HY，Zhou M，et al.The molecular mechanism involved in the development of nasopharyngeal carcinoma [J].Sheng Wu Hua Xue Yu Sheng Wu Wu Li Jin Zhan，2006，33 (10)：922-931.[李桂源，刘华英，周鸣，等.鼻咽癌癌变的分子机理[J].生物化学与生物物理进展，2006，33 (10)：922-931.] [10] Qian SB，McDonough H，Boellmann F，et al.CHIP-mediated stress recovery by sequential ubiquitination of substrates and Hsp70 [J].Nature，2006，440 (7083)：551-555. [11] Parcellier A，Schmitt E，Brunet M，et al.Small heat shock proteins HSP27 and alphaB-crystallin：cytoprotective and oncogenic functions [J].Antioxid Redox Signal，2005，7 (3-4)：404-413. [12] Rocchi P，So A，Kojima S，et al.Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer [J].Cancer Res，2004，64 (18)：6595-6602. [13] Garrido C，Bruey J M，Fromentin A，et al.HSP27 inhibits cytochrome c-dependent activation of procaspase-9 [J].FASEB J，1999，13 (14)：2061-2070. [14] Paul C，Manero F，Gonin S，et al.Hsp27 as a negative regulator of cytochrome C release [J].Mol Cell Biol，2002，22 (3)：816-834. [15] Parcellier A，Schmitt E，Gurbuxani S，et al.HSP27 is a ubiquitin-binding protein involved in I-kappaB alpha proteasomal degradation [J].Mol Cell Biol，2003，23 (16)：5790-5802. [16] Parcellier A，Brunet M，Schmitt E，et al.HSP27 favors ubiquitination and proteasomal degradation of p27Kip1 and helps S-phase re-entry in stressed cells [J].FASEB J，2006，20 (8)：1179-1181.
计量
- 文章访问数: 2655
- HTML全文浏览量: 17
- PDF下载量: 730
下载:
